Page last updated: 2024-11-01

nortriptyline and Infant, Newborn, Diseases

nortriptyline has been researched along with Infant, Newborn, Diseases in 1 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shearer, WT1
Schreiner, RL1
Marshall, RE1

Other Studies

1 other study available for nortriptyline and Infant, Newborn, Diseases

ArticleYear
Urinary retention in a neonate secondary to maternal ingestion of nortriptyline.
    The Journal of pediatrics, 1972, Volume: 81, Issue:3

    Topics: Adult; Depression; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Maternal-Fetal

1972